Symposia: Lymphomas: Translational – Non-Genetic
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Combination therapy, Adult, Fundamental Science, Translational Research, Lymphomas, Non-Hodgkin lymphoma, Clinical Practice (Health Services and Quality), Drug development, B Cell lymphoma, Chimeric Antigen Receptor (CAR)-T Cell Therapies, Diseases, Indolent lymphoma, Immune mechanism, Aggressive lymphoma, Treatment Considerations, Biological therapies, Immunology, Lymphoid Malignancies, Computational biology, Biological Processes, Microbiome, Technology and Procedures, Human, Study Population, Imaging, Measurable Residual Disease , Molecular testing, Omics technologies, Serologic Tests
Type: Oral
Hematology Disease Topics & Pathways:
Research, Combination therapy, Adult, Fundamental Science, Translational Research, Lymphomas, Non-Hodgkin lymphoma, Clinical Practice (Health Services and Quality), Drug development, B Cell lymphoma, Chimeric Antigen Receptor (CAR)-T Cell Therapies, Diseases, Indolent lymphoma, Immune mechanism, Aggressive lymphoma, Treatment Considerations, Biological therapies, Immunology, Lymphoid Malignancies, Computational biology, Biological Processes, Microbiome, Technology and Procedures, Human, Study Population, Imaging, Measurable Residual Disease , Molecular testing, Omics technologies, Serologic Tests
Sunday, December 8, 2024: 4:30 PM-6:00 PM
Pacific Ballroom Salons 15-17
(Marriott Marquis San Diego Marina)
Moderators:
Santosha A. Vardhana, MD, PhD,
and
Benoit Tessoulin, CHU Nantes
Disclosures:
No relevant conflicts of interest to declare.
This session will describe the lymphoma TME and how new therapies interact with this complex immune: tumour interface.
4:30 PM
4:45 PM
5:00 PM
5:15 PM
5:30 PM
5:45 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH